Cargando…

P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE

Detalles Bibliográficos
Autores principales:	D’agostino, Mattia, Bringhen, Sara, Giuliani, Nicola, Antonioli, Elisabetta, Zambello, Renato, Cattel, Francesco, Ria, Roberto, Allegra, Alessandro, Leonardi, Giovanna, Belotti, Angelo, Galieni, Piero, Margiotta-Casaluci, Gloria, Cantonetti, Maria, Cotugno, Valentina, Gamberi, Barbara, Pane, Fabrizio, Liberati, Anna Marina, Tosi, Patrizia, Cavalli, Maide Maria, Mannina, Donato, Benevolo, Giulia, Mangiacavalli, Silvia, Evangelista, Andrea, Ciccone, Giovannino, Boccadoro, Mario, Bruno, Benedetto, Larocca, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430276/ http://dx.doi.org/10.1097/01.HS9.0000973592.99386.9a

Ejemplares similares

P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL
por: Larocca, A., et al.
Publicado: (2023)

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials
por: Larocca, Alessandra, et al.
Publicado: (2020)

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial
por: Mina, Roberto, et al.
Publicado: (2021)

Jan Swammerdam (1637–1680). His Life and Works
por: Towers, Bernard
Publicado: (1969)

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
por: Bonello, Francesca, et al.
Publicado: (2020)

La comedia española (1600-1680) /
por: Aubrun, Charles Vincent, 1906-
Publicado: (1968)

Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma
por: Bonello, Francesca, et al.
Publicado: (2022)

Knowledge and practice in English medicine, 1550–1680
por: Bates, Don
Publicado: (2002)

John Addenbrooke M.D. (1680-1719).
por: Rook, A, et al.
Publicado: (1982)

Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell Transplantation
por: Buda, Gabriele, et al.
Publicado: (2021)

Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies
por: Mina, Roberto, et al.
Publicado: (2020)

Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience
por: Moretti, Marina, et al.
Publicado: (2022)

Circulation physiology and medical chemistry in England 1650–1680
Publicado: (1975)

Augustan England. Professions, state, and society, 1680–1730
por: Porter, Roy
Publicado: (1983)

Passages of Medical History. Edinburgh Medicine, 1680-1750
por: Comrie, John D.
Publicado: (1936)

Before Voltaire: the French origins of "Newtonian" mechanics, 1680-1715
por: Shank, JB
Publicado: (2018)

Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis
por: Hungria, Vania, et al.
Publicado: (2020)

Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus
por: Mario, Boccadoro, et al.
Publicado: (2021)

Partidos y padrones del Obispado de Michoacán, 1680-1685
por: Carrillo Cázares, Alberto
Publicado: (1996)

1680. Evaluation of the Urinalysis Reflex to Culture Sensitivity and Impact on Antibiotic Utilization
por: Wellen, Jacob, et al.
Publicado: (2020)

The Ineligibility of Antipyrin in Pneumonia
Publicado: (1886)

The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan
por: Du, Jeng-Shiun, et al.
Publicado: (2022)

Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies
por: Bringhen, Sara, et al.
Publicado: (2019)

La filosofía del amor en la literatura española 1480-1680 /
por: Parker, Alexander A. (Alexander Augustine), 1908-1989
Publicado: (1986)

Los orígenes de la ciencia moderna en México (1630-1680)
por: Trabulse, Elías
Publicado: (1994)

Fevers and other fundamentals: Dutch and German medical explanations c. 1680 to 1730.
por: Geyer-Kordesch, J.
Publicado: (1981)

The virtues of the cortex in 1680: a letter from Charles Goodall to Mr. H.
por: Davis, A B
Publicado: (1971)

Environmental Occurrence and Predicted Pharmacological Risk to Freshwater Fish of over 200 Neuroactive Pharmaceuticals in Widespread Use
por: Sumpter, John P., et al.
Publicado: (2022)

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
por: Kim, Min Kyoung, et al.
Publicado: (2017)

Whole-Genome Sequence for Methicillin-Resistant Staphylococcus aureus Strain ATCC BAA-1680
por: Daum, Luke T., et al.
Publicado: (2015)

Testicular sperm extraction in men with sertoli cell-only testicular histology - 1680 cases
por: Taitson, Paulo Franco, et al.
Publicado: (2019)

Notes on the Intestinal Protozoal Infections of 1680 Men Examined at the University War Hospital, Southampton
Publicado: (1919)

Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial
por: Knop, Stefan, et al.
Publicado: (2021)

Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score
por: D’Agostino, Mattia, et al.
Publicado: (2021)

Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients
por: Ocio, Enrique M., et al.
Publicado: (2023)

A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma
por: San-Miguel, Jesús F., et al.
Publicado: (2018)

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True
por: D’Agostino, Mattia, et al.
Publicado: (2020)

Los otomíes de San Nicolás de tierranueva Río de Jofre : 1680-1794 /
por: Rivera Villanueva, José Antonio
Publicado: (2007)

Doctors and slaves. A medical and demographic history of slavery in the British West Indies, 1680—1834
por: Stuart, Barbara
Publicado: (1986)

Visible Labour? Productive Forces and Imaginaries of Participation in European Insect Studies, ca. 1680–1810
por: Hünniger, Dominik
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ifvl25ure2pf5tg5ho3k5i9krl